FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ralph Edwards

Research Profile

Concepts & Ideas

Activities & Behaviors

Chemicals & Drugs

Disorders

Drug Toxicity

Procedures

Co-author Network

Publications

TOP 3
Johanna Strandell; Ola Caster; I Ralph Edwards; Johan Hopstadius; Niklas Norén
The development and evaluation of triage algorithms for early discovery of adverse drug interactions.
Kristina Star; Karin Nordin; Ulrika Pöder; I Ralph Edwards
Challenges of safe medication practice in paediatric care - a nursing perspective.
K C Santosh; Sarun Gorsanan; Pramote Tragulpiankit; I Ralph Edwards
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ralph Edwards (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johanna Strandell; Ola Caster; I Ralph Edwards; Johan Hopstadius; Niklas Norén
The development and evaluation of triage algorithms for early discovery of adverse drug interactions.
Drug safety : an international journal of medical toxicology and drug experience 2013;36(5):371-88.
2013: Kristina Star; Karin Nordin; Ulrika Pöder; I Ralph Edwards
Challenges of safe medication practice in paediatric care - a nursing perspective.
Acta paediatrica (Oslo, Norway : 1992) 2013;102(5):532-8.
2013: K C Santosh; Sarun Gorsanan; Pramote Tragulpiankit; I Ralph Edwards
Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.
BMC pharmacology & toxicology 2013;14():16.
2013: K C Santosh; Pramote Tragulpiankit; I Ralph Edwards; Sarun Gorsanan
Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
The International journal of risk & safety in medicine 2013;25(1):1-16.
2012: Kristina Star; Lynda Wilton; Noor B Almandil; Sarah Curran; I Ralph Edwards; Noha Iessa; Ian C K Wong
Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
Journal of child and adolescent psychopharmacology 2012;22(6):440-51.
2012: I Ralph Edwards
Communicating the new pharmacovigilance landscape.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(12):1085-9.
2012: Ola Caster; Love Ekenberg; G Niklas Norén; I Ralph Edwards
Quantitative benefit-risk assessment using only qualitative information on utilities.
Medical decision making : an international journal of the Society for Medical Decision Making 2012;32(6):E1-15.
2012: I Ralph Edwards
Decision dilemmas: worse in emerging economies.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(8):611-4.
2012: I Ralph Edwards
Good pharmacovigilance practice and the curate's egg.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(6):429-35.
2012: I Ralph Edwards
Pharmacovigilance.
British journal of clinical pharmacology 2012;73(6):979-82.
2012: I Ralph Edwards
Clinical diagnosis: a topic worth revisiting for pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(4):261-4.
2012: I Ralph Edwards
Prevention and pharmacovigilance: what should we do, what can we do?
Drug safety : an international journal of medical toxicology and drug experience 2012;35(2):87-90.
2012: I Ralph Edwards
Considerations on causality in pharmacovigilance.
The International journal of risk & safety in medicine 2012;24(1):41-54.
2012: I Ralph Edwards; David Body
Forensic pharmacovigilance.
The International journal of risk & safety in medicine 2012;24(1):1-2.
2011: I Ralph Edwards
Patient follow-up and monitoring medicines.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(12):1121-3.
2011: Priya Bahri; I Ralph Edwards; Peter G M Mol; Hélène Théophile; Bruce P J Hugman
Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(10):881-2.
2011: I Ralph Edwards
Off-label pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(10):795-7.
2011: I Ralph Edwards
The Author's Reply.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(9):793-4.
2011: I Ralph Edwards
Conflicts of interest in medicines safety and regulation: how much conflict and how much interest should we allow?
Drug safety : an international journal of medical toxicology and drug experience 2011;34(8):617-21.
2011: Niklas Norén; Johan Hopstadius; Andrew Bate; I Ralph Edwards
Safety surveillance of longitudinal databases: methodological considerations.
Pharmacoepidemiology and drug safety 2011;20(7):714-7.
2011: I Ralph Edwards
Fraudulent and substandard medicines: getting away with murder?
Drug safety : an international journal of medical toxicology and drug experience 2011;34(6):445-8.
2011: Kristina Star; Niklas Norén; Karin Nordin; I Ralph Edwards
Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(5):415-28.
2011: Kristina Star; Ola Caster; Andrew Bate; I Ralph Edwards
Dose variations associated with formulations of NSAID prescriptions for children: a descriptive analysis of electronic health records in the UK.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(4):307-17.
2011: I Ralph Edwards; Marie Lindquist
Social media and networks in pharmacovigilance: boon or bane?
Drug safety : an international journal of medical toxicology and drug experience 2011;34(4):267-71.
2011: Johanna Strandell; Ola Caster; Andrew Bate; Niklas Norén; I Ralph Edwards
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(3):253-66.
2011: Ola Caster; I Ralph Edwards; G Niklas Norén; Marie Lindquist
Earlier discovery of pregabalin's dependence potential might have been possible.
European journal of clinical pharmacology 2011;67(3):319-20.
2011: I Ralph Edwards; Ambrose Isah
Pharmacovigilance and the null hypothesis: do we do much for public health?
Drug safety : an international journal of medical toxicology and drug experience 2011;34(2):93-6.
2011: David Body; I Ralph Edwards; Kenneth Hartigan Go; David Healy; Andrew Herxheimer; Jeremy Labadie
Is there a need for forensic pharmacovigilance as a specialty?
The International journal of risk & safety in medicine 2011;23(1):31-42.
2011: Ghita Benabdallah; Raja Benkirane; asmae khattabi; I Ralph Edwards; Rachida Soulaymani Bencheikh
The involvement of Pharmacovigilance Centres in medication errors detection: a questionnaire-based analysis.
The International journal of risk & safety in medicine 2011;23(1):17-29.
2010: I Ralph Edwards
African heat.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(12):1059-63.
2010: Kristina Star; Andrew Bate; Ronald H B Meyboom; I Ralph Edwards
Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern?
The British journal of general practice : the journal of the Royal College of General Practitioners 2010;60(579):e385-94.
2010: Ola Caster; I Ralph Edwards
Reflections on attribution and decisions in pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(10):805-9.
2010: I Ralph Edwards; Teresa Graedon
What do stakeholders think about pharmacovigilance?
Drug safety : an international journal of medical toxicology and drug experience 2010;33(8):619-21.
2010: I Ralph Edwards; Joe Graedon; Terry Graedon
Placebo harm.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(6):439-41.
2010: I Ralph Edwards; Marie Lindquist
First, catch your signal!
Drug safety : an international journal of medical toxicology and drug experience 2010;33(4):257-60.
2010: I Ralph Edwards
Wonder vigilance.
Drug safety : an international journal of medical toxicology and drug experience 2010;33(2):83-6.
2009: G Niklas Norén; I Ralph Edwards
Modern methods of pharmacovigilance: detecting adverse effects of drugs.
Clinical medicine (London, England) 2009;9(5):486-9.
2009: Johanna Strandell; Andrew Bate; Staffan Hägg; I Ralph Edwards
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
British journal of clinical pharmacology 2009;68(3):427-34.
2009: I Ralph Edwards
Tomorrow's world.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(12):1105-8.
2009: I Ralph Edwards
A risk worth taking?
Drug safety : an international journal of medical toxicology and drug experience 2009;32(10):801-4.
2009: I Ralph Edwards
Outliers and patients with adverse drug reactions.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(8):623-4.
2009: I Ralph Edwards; Marie Lindquist
Understanding and communicating key concepts in risk management: what do we mean by benefit and risk?
Drug safety : an international journal of medical toxicology and drug experience 2009;32(6):449-52.
2009: I Ralph Edwards
The good old drugs!
Drug safety : an international journal of medical toxicology and drug experience 2009;32(4):271-3.
2009: I Ralph Edwards
The ISoP Bengt-Erik Wiholm Memorial Lecture.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(3):181-5.
2009: I Ralph Edwards
Risk management of medicines and compensation for harm.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(2):87-90.
2008: Niklas Norén; Rolf Sundberg; Andrew Bate; I Ralph Edwards
A statistical methodology for drug-drug interaction surveillance.
Statistics in medicine 2008;27(16):3057-70.
2008: Andrew Bate; Marie Lindquist; I Ralph Edwards
The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
Fundamental & clinical pharmacology 2008;22(2):127-40.
2008: I Ralph Edwards
The future of pharmacovigilance: a personal view.
European journal of clinical pharmacology 2008;64(2):173-81.
2008: Johan Hopstadius; Niklas Norén; Andrew Bate; I Ralph Edwards
Stratification for spontaneous report databases.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(12):1145-7.
2008: Johan Hopstadius; Niklas Norén; Andrew Bate; I Ralph Edwards
Impact of stratification on adverse drug reaction surveillance.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(11):1035-48.
2008: I Ralph Edwards
Controlled trials and risk of harm.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(11):961-3.
2008: Ronald H B Meyboom; Kristina Star; Jenny Bate; Ruth Savage; I Ralph Edwards
TNF-alpha inhibitors and leukaemia: international pharmacovigilance reports.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(5):445-7.
2008: Johanna Strandell; Andrew Bate; Marie Lindquist; I Ralph Edwards
Drug-drug interactions - a preventable patient safety issue?
British journal of clinical pharmacology 2008;65(1):144-6.
2007: William N Kelly; Felix M Arellano; Joanne Barnes; Ulf Bergman; I Ralph Edwards; Alina M Fernandez; Stephen B Freedman; David Goldsmith; Kui Huang; Judith K Jones; Rachel McLeay; nicholas moore; Rosie H Stather; Thierry Trenque; William G Troutman; Eugene van Puijenbroek; Frank Williams; Robert P Wise
Guidelines for submitting adverse event reports for publication.
Pharmacoepidemiology and drug safety 2007;16(5):581-7.
2007: I Ralph Edwards; Kristina Star; Anne Kiuru
Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(6):515-25.
2006: Niklas Norén; Andrew Bate; Roland Orre; I Ralph Edwards
Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events.
Statistics in medicine 2006;25(21):3740-57.
2006: Bruce Hugman; I Ralph Edwards
The challenge of effectively communicating patient safety information.
Expert opinion on drug safety 2006;5(4):495-9.
2006: Andrew Bate; I Ralph Edwards
Data mining in spontaneous reports.
Basic & clinical pharmacology & toxicology 2006;98(3):324-30.
2006: I Ralph Edwards
What is drug safety?: celebrating 20 years of the Drug Safety journal.
Drug safety : an international journal of medical toxicology and drug experience 2006;29(6):461-5.
2005: Marissa Lassere; Kent R Johnson; Maarten Boers; Kerri Carlton; Richard O Day; Marten de Wit; I Ralph Edwards; James F Fries; Daniel E Furst; John R Kirwan; Peter Tugwell; Thasia G Woodworth; Peter M Brooks
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
The Journal of rheumatology 2005;32(10):2037-41.
2005: Roland Orre; Andrew Bate; Niklas Norén; Erik Swahn; Stefan Arnborg; I Ralph Edwards
A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets.
International journal of neural systems 2005;15(3):207-22.
2005: I Ralph Edwards
What are the real lessons from Vioxx?
Drug safety : an international journal of medical toxicology and drug experience 2005;28(8):651-8.
2005: I Ralph Edwards
The WHO World Alliance for Patient Safety: a new challenge or an old one neglected?
Drug safety : an international journal of medical toxicology and drug experience 2005;28(5):379-86.
2004: Ronald H B Meyboom; I Ralph Edwards
Rosuvastatin and the statin wars--the way to peace.
Lancet 2004;364(9450):1997-9.
2004: I Ralph Edwards
Intuition, evidence, and safety.
Lancet 2004;364(9431):387.
2004: Malin Ståhl; Marie Lindquist; I Ralph Edwards; E G Brown
Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database.
Pharmacoepidemiology and drug safety 2004;13(6):355-63.
2003: David W J Clark; Ana-Maria Correa-Nunes; I Ralph Edwards
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome).
European journal of clinical pharmacology 2003;59(3):261-2.
2003: I Ralph Edwards
Withdrawing drugs: nefazodone, the start of the latest saga.
Lancet 2003;361(9365):1240.
2003: Malin Ståhl; I Ralph Edwards; Geoffrey Bowring; Anne Kiuru; Marie Lindquist
Assessing the impact of drug safety signals from the WHO database presented in 'SIGNAL': results from a questionnaire of National pharmacovigilance Centres.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(10):721-7.
2002: Andrew Bate; Marie Lindquist; Roland Orre; I Ralph Edwards; Ronald H B Meyboom
Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
European journal of clinical pharmacology 2002;58(7):483-90.
2002: A C Kees van Grootheest; I Ralph Edwards
Labelling and 'Dear Doctor' letters: are they noncommittal?
Drug safety : an international journal of medical toxicology and drug experience 2002;25(15):1051-5.
2002: Ronald H B Meyboom; Marie Lindquist; Toine Egberts; I Ralph Edwards
Signal selection and follow-up in pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(6):459-65.
2002: Andrew Bate; Marie Lindquist; I Ralph Edwards; Roland Orre
A data mining approach for signal detection and analysis.
Drug safety : an international journal of medical toxicology and drug experience 2002;25(6):393-7.
2001: I Ralph Edwards
The management of adverse drug reactions: from diagnosis to signal.
Thérapie 2001;56(6):727-33.
2001: David M Coulter; Andrew Bate; Ronald H B Meyboom; Marie Lindquist; I Ralph Edwards
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study.
BMJ (Clinical research ed.) 2001;322(7296):1207-9.
2001: Marie Lindquist; I Ralph Edwards
The WHO Programme for International Drug Monitoring, its database, and the technical support of the Uppsala Monitoring Center.
The Journal of rheumatology 2001;28(5):1180-7.
2000: Marie Lindquist; Malin Ståhl; Andrew Bate; I Ralph Edwards; Ronald H B Meyboom
A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.
Drug safety : an international journal of medical toxicology and drug experience 2000;23(6):533-42.
2000: I Ralph Edwards; J K Aronson
Adverse drug reactions: definitions, diagnosis, and management.
Lancet 2000;356(9237):1255-9.
2000: Ronald H B Meyboom; Marie Lindquist; A K Flygare; C Biriell; I Ralph Edwards
The value of reporting therapeutic ineffectiveness as an adverse drug reaction.
Drug safety : an international journal of medical toxicology and drug experience 2000;23(2):95-9.
2000: I Ralph Edwards
Spontaneous ADR reporting and drug safety signal induction in perspective. To honour Professor Jens Schou.
Pharmacology & toxicology 2000;86 Suppl 1():16-9.
1999: Philip A Routledge; Marie Lindquist; I Ralph Edwards
Spontaneous reporting of suspected adverse reactions to antihistamines: a national and international perspective.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999;29 Suppl 3():240-6; discussion 247-50.
1999: Marie Lindquist; I Ralph Edwards; Andrew Bate; H Fucik; A M Nunes; Malin Ståhl
From association to alert--a revised approach to international signal analysis.
Pharmacoepidemiology and drug safety 1999;8 Suppl 1():S15-25.
1999: Ronald H B Meyboom; I Ralph Edwards; A C Egberts
Mirtazapine and the granulocytes--so far so good.
The New Zealand medical journal 1999;112(1084):104.
1998: Andrew Bate; Marie Lindquist; I Ralph Edwards; Sten Olsson; Roland Orre; A Lansner; R M De Freitas
A Bayesian neural network method for adverse drug reaction signal generation.
European journal of clinical pharmacology 1998;54(4):315-21.
1997: Ronald H B Meyboom; YA Hekster; Toine Egberts; FW Gribnau; I Ralph Edwards
Causal or casual? The role of causality assessment in pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 1997;17(6):374-89.
1997: I Ralph Edwards; Bruce Hugman
The challenge of effectively communicating risk-benefit information.
Drug safety : an international journal of medical toxicology and drug experience 1997;17(4):216-27.
1997: Ronald H B Meyboom; Toine Egberts; I Ralph Edwards; YA Hekster; Fred H P De Koning; FW Gribnau
Principles of signal detection in pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 1997;16(6):355-65.
1997: Marie Lindquist; I Ralph Edwards
Risks of non-sedating antihistamines.
Lancet 1997;349(9061):1322.
1997: Marie Lindquist; M Pettersson; I Ralph Edwards; J H Sanderson; N F Taylor; A P Fletcher; J S Schou; R Savage
How does cystitis affect a comparative risk profile of tiaprofenic acid with other non-steroidal antiinflammatory drugs? An international study based on spontaneous reports and drug usage data. ADR Signals Analysis Project (ASAP) Team.
Pharmacology & toxicology 1997;80(5):211-7.
1997: C Biriell; I Ralph Edwards
Reasons for reporting adverse drug reactions--some thoughts based on an international review.
Pharmacoepidemiology and drug safety 1997;6(1):21-6.
1997: M M Stahl; Marie Lindquist; M Pettersson; I Ralph Edwards; J H Sanderson; N F Taylor; A P Fletcher; J S Schou
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
European journal of clinical pharmacology 1997;53(3-4):163-9.
1997: I Ralph Edwards
Who cares about pharmacovigilance?
European journal of clinical pharmacology 1997;53(2):83-8.
1996: Marie Lindquist; M Pettersson; I Ralph Edwards; J Sanderson; N Taylor; P Fletcher; J Schou; T Fraunfelder
Omeprazole and visual disorders: seeing alternatives.
Pharmacoepidemiology and drug safety 1996;5(1):27-32.
1992: Marie Lindquist; I Ralph Edwards
Reporting side-effects.
Lancet 1992;340(8826):1043.
1992: S Olsson; I Ralph Edwards
Tachycardia during cisapride treatment.
BMJ (Clinical research ed.) 1992;305(6856):748-9.
1992: Marie Lindquist; I Ralph Edwards
Endocrine adverse effects of omeprazole.
BMJ (Clinical research ed.) 1992;305(6851):451-2.
1992: D G Ferry; A J Campbell; R Bland; M Beasley; L Gazeley; I Ralph Edwards
Pharmacokinetics of pirmenol in young and elderly subjects.
European journal of clinical pharmacology 1992;43(4):437-9.
1990: David M Coulter; I Ralph Edwards
Mianserin and agranulocytosis in New Zealand.
Lancet 1990;336(8718):785-7.
1990: I Ralph Edwards; Marie Lindquist; B E Wiholm; E Napke
Quality criteria for early signals of possible adverse drug reactions.
Lancet 1990;336(8708):156-8.
1990: David M Coulter; I Ralph Edwards; R L Savage
Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme.
The New Zealand medical journal 1990;103(885):98-100.
1990: G S Elliott; R W Mason; I Ralph Edwards
Studies on the pharmacokinetics and mutagenic potential of rhodamine B.
Journal of toxicology. Clinical toxicology 1990;28(1):45-59.
1990: D G Ferry; L R Gazeley; W J Busby; D M Beasley; I Ralph Edwards; A J Campbell
Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine.
European journal of clinical pharmacology 1990;39(6):599-601.
1989: R W Mason; I Ralph Edwards
High-performance liquid chromatographic determination of rhodamine B in rabbit and human plasma.
Journal of chromatography 1989;491(2):468-72.
1988: I Ralph Edwards; M G Beasley; David M Coulter
Drug reactions. Medicines Adverse Reactions Committee: report for the two years ending March 1987.
The New Zealand medical journal 1988;101(859):826-8.
1988: D W Clark; I Ralph Edwards
Adverse drug reaction reporting and retrospective phenotyping for oxidation polymorphism.
Medical toxicology and adverse drug experience 1988;3(3):241-7.
1988: B R Dobbs; L R Gazeley; I A Stewart; I Ralph Edwards
Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days.
The Journal of antimicrobial chemotherapy 1988;21 Suppl B():61-6.
1988: L J Schaaf; B R Dobbs; I Ralph Edwards; D G Perrier
The in vitro stability of doxifluridine in whole blood and plasma.
European journal of clinical pharmacology 1988;34(5):533-4.
1988: L J Schaaf; B R Dobbs; I Ralph Edwards; D G Perrier
The pharmacokinetics of doxifluridine and 5-fluorouracil after single intravenous infusions of doxifluridine to patients with colorectal cancer.
European journal of clinical pharmacology 1988;34(5):439-43.
1987: I Ralph Edwards
Adverse drug reaction monitoring. The practicalities.
Medical toxicology and adverse drug experience 1987;2(6):405-10.
1987: L J Schaaf; B R Dobbs; I Ralph Edwards; D G Perrier
Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients.
European journal of clinical pharmacology 1987;32(4):411-8.
1987: B R Dobbs; L R Gazeley; A J Campbell; I Ralph Edwards
The effect of age on the pharmacokinetics of enoxacin.
European journal of clinical pharmacology 1987;33(1):101-4.
1986: I Ralph Edwards; David M Coulter; M G Beasley
Medicines Adverse Reactions Committee: report for the two years ending March 1985.
The New Zealand medical journal 1986;99(810):719-22.
1985: L J Schaaf; D G Ferry; C T Hung; D G Perrier; I Ralph Edwards
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography.
Journal of chromatography 1985;342(2):303-13.
1985: A J Campbell; D G Ferry; I Ralph Edwards
Pharmacokinetic projections for isoxicam and piroxicam in old and young subjects.
British journal of rheumatology 1985;24(2):176-8.
1985: I Ralph Edwards; D G Ferry; A J Campbell
Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam.
European journal of clinical pharmacology 1985;28(6):689-92.